Ocular Drug Delivery Systems MCQs With Answer

Introduction:

Ocular Drug Delivery Systems MCQs With Answer

This quiz compilation is designed for M.Pharm students studying Novel Drug Delivery Systems (MIP 103T), focusing on ocular drug delivery. It covers anatomy-related barriers, formulation strategies (drops, ointments, gels, inserts, implants), advanced carriers (nanoparticles, liposomes, dendrimers), and routes (topical, intravitreal, periocular). Emphasis is placed on factors controlling corneal permeability, tear dynamics, drug retention, sterilization challenges, and biocompatibility. Each multiple-choice question tests conceptual understanding and practical formulation considerations needed for designing effective, safe ophthalmic therapies, with clear answers to aid revision and exam preparation.

Q1. Which of the following is the primary static barrier limiting transcorneal drug absorption for topical ophthalmic formulations?

• Stromal collagen layer due to dense hydrophilic matrix
• Corneal epithelium because of tight junctions and lipophilic cell membranes
• Endothelial pump function actively removing drug
• Tear film mucin layer preventing drug contact

Correct Answer: Corneal epithelium because of tight junctions and lipophilic cell membranes

Q2. Which formulation strategy most effectively increases precorneal residence time without significantly blurring vision?

• Increasing solution viscosity using high molecular weight polymers to form mucoadhesive gels
• Converting drug into an oil-based ointment for prolonged release
• Adding hyperosmotic agents to shrink conjunctival tissue
• Using large particulate suspensions (>50 µm) to reduce drainage

Correct Answer: Increasing solution viscosity using high molecular weight polymers to form mucoadhesive gels

Q3. Which property of nanoparticles is most critical to enhance corneal penetration and cell uptake in ocular delivery?

• Neutral surface charge to avoid interaction with mucin
• Hydrodynamic diameter below ~200 nm and surface modification for mucoadhesion
• Particle rigidity exceeding stromal mesh size
• Highly hydrophobic surface to partition into tear lipids

Correct Answer: Hydrodynamic diameter below ~200 nm and surface modification for mucoadhesion

Q4. Which in situ gelling mechanism depends on temperature change at the ocular surface?

• Ion-activated gelation using divalent cations in tears
• pH-triggered gelation by rise in ocular pH
• Thermosensitive gelation using polymers like poloxamer
• Enzymatic crosslinking by tear enzymes

Correct Answer: Thermosensitive gelation using polymers like poloxamer

Q5. Which preservative is most commonly associated with ocular surface toxicity and should be avoided in chronic eyedrop therapy?

• Benzalkonium chloride (BAK)
• Sodium chlorite
• Polyquaternium-1 (Polyquad)
• Disodium edetate (EDTA)

Correct Answer: Benzalkonium chloride (BAK)

Q6. For intravitreal injections, which factor is most important to minimize endotoxin-related inflammation?

• Use of oils with low peroxide value
• Sterile filtration through 0.45 µm filters immediately before injection
• Aseptic manufacturing and validated endotoxin control with <0.5 EU/mL limits
• Lyophilization of formulation to remove pyrogens

Correct Answer: Aseptic manufacturing and validated endotoxin control with <0.5 EU/mL limits

Q7. Which ocular delivery system is designed to provide sustained drug release over weeks to months and is surgically implanted?

• Soluble in situ gelling drops
• Sustained-release contact lenses
• Biodegradable intravitreal implant
• Topical ointment

Correct Answer: Biodegradable intravitreal implant

Q8. Which formulation parameter primarily determines the rate of drug clearance from the precorneal area?

• Tear turnover rate and nasolacrimal drainage
• Drug melting point
• Corneal endothelial pump activity
• Systemic hepatic clearance

Correct Answer: Tear turnover rate and nasolacrimal drainage

Q9. Prodrug approaches for ocular delivery (e.g., dipivefrin from epinephrine) mainly aim to:

• Increase molecular weight to reduce absorption
• Enhance corneal permeability by improving lipophilicity and then convert to active drug within the eye
• Prevent drug metabolism by ocular enzymes
• Make the drug more soluble in tears

Correct Answer: Enhance corneal permeability by improving lipophilicity and then convert to active drug within the eye

Q10. Which ocular route bypasses the blood–retinal barrier most directly for delivering drugs to the posterior segment?

• Topical conjunctival application
• Systemic oral administration
• Intravitreal injection
• Transscleral iontophoresis

Correct Answer: Intravitreal injection

Q11. Which sterilization method is least suitable for protein-based biologic ophthalmic formulations due to denaturation?

• Filtration through 0.22 µm sterile filters
• Autoclaving (moist heat) at 121°C
• Gamma irradiation with dose optimization
• Use of aseptic processing without terminal sterilization

Correct Answer: Autoclaving (moist heat) at 121°C

Q12. In contact lens–based drug delivery, which parameter controls drug loading and release most directly?

• Lens optical power
• Hydrophilicity and water content of the lens polymer matrix
• Lens edge shape
• Ambient humidity

Correct Answer: Hydrophilicity and water content of the lens polymer matrix

Q13. Which vesicular carrier is composed of non-ionic surfactants and offers improved chemical stability compared to liposomes?

• Solid lipid nanoparticles
• Niosomes
• Dendrimers
• Silica nanoparticles

Correct Answer: Niosomes

Q14. A major advantage of ocular inserts (e.g., punctal plugs or solid inserts) over conventional eyedrops is:

• Higher systemic absorption through conjunctiva
• Single-use disposable format only
• Sustained and controlled drug release with reduced dosing frequency
• Elimination of need for sterility

Correct Answer: Sustained and controlled drug release with reduced dosing frequency

Q15. Which statement best describes the role of zeta potential in ocular nanoparticle formulations?

• Zeta potential determines color of the formulation
• High absolute zeta potential increases colloidal stability and affects mucoadhesion/interaction with ocular surface
• Zeta potential correlates directly with drug potency
• Zero zeta potential always ensures best corneal penetration

Correct Answer: High absolute zeta potential increases colloidal stability and affects mucoadhesion/interaction with ocular surface

Q16. Which ocular disease indication is most appropriately treated by intravitreal sustained-release corticosteroid implants?

• Anterior blepharitis
• Chronic non-infectious uveitis affecting the posterior segment
• Recurrent conjunctival papilloma
• Dry eye syndrome limited to tear deficiency

Correct Answer: Chronic non-infectious uveitis affecting the posterior segment

Q17. Which factor is most responsible for poor bioavailability (<5%) of many topically applied ophthalmic drugs?

• Rapid blinking and nasolacrimal drainage combined with limited corneal permeability
• Excessive drug partitioning into the lens
• Immediate systemic metabolism in the conjunctiva
• Drug evaporation from the tear film

Correct Answer: Rapid blinking and nasolacrimal drainage combined with limited corneal permeability

Q18. Which analytical parameter is most critical when developing ophthalmic suspensions to ensure uniform dosing?

• Sedimentation volume and redispersibility of particles
• Color matching with ocular tissues
• Viscosity at 1000 s^-1 shear rate only
• Drug hygroscopicity under zero humidity

Correct Answer: Sedimentation volume and redispersibility of particles

Q19. Gene therapy targeting retinal cells via subretinal injection primarily requires delivery across which barrier?

• Corneal epithelial tight junctions
• Inner limiting membrane and photoreceptor-RPE interface
• Nasolacrimal duct epithelium
• Lacrimal gland capsule

Correct Answer: Inner limiting membrane and photoreceptor-RPE interface

Q20. When designing ophthalmic emulsions for lipophilic drugs, which emulsifier attribute is most important to minimize ocular irritation?

• High ionic strength to increase osmolarity
• Use of non-ionic, ophthalmic-grade surfactants with proven ocular compatibility
• Strong cationic charge to enhance tissue binding
• Use of industrial detergents to stabilize droplets

Correct Answer: Use of non-ionic, ophthalmic-grade surfactants with proven ocular compatibility

Download